These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 25363455)

  • 21. The use of primaquine in malaria infected patients with red cell glucose-6-phosphate dehydrogenase (G6PD) deficiency in Myanmar.
    Myat-Phone-Kyaw ; Myint-Oo ; Aung-Naing ; Aye-Lwin-Htwe
    Southeast Asian J Trop Med Public Health; 1994 Dec; 25(4):710-3. PubMed ID: 7667719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemolytic Dynamics of Weekly Primaquine Antirelapse Therapy Among Cambodians With Acute Plasmodium vivax Malaria With or Without Glucose-6-Phosphate Dehydrogenase Deficiency.
    Taylor WRJ; Kheng S; Muth S; Tor P; Kim S; Bjorge S; Topps N; Kosal K; Sothea K; Souy P; Char CM; Vanna C; Ly P; Khieu V; Christophel E; Kerleguer A; Pantaleo A; Mukaka M; Menard D; Baird JK
    J Infect Dis; 2019 Oct; 220(11):1750-1760. PubMed ID: 31549159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primaquine-induced haemolysis in females heterozygous for G6PD deficiency.
    Chu CS; Bancone G; Nosten F; White NJ; Luzzatto L
    Malar J; 2018 Mar; 17(1):101. PubMed ID: 29499733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primaquine or other 8-aminoquinolines for reducing Plasmodium falciparum transmission.
    Graves PM; Choi L; Gelband H; Garner P
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD008152. PubMed ID: 29393511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of Glucose 6-Phosphate Dehydrogenase Variants in Malaria-Endemic Areas of South Central Timor, Eastern Indonesia.
    Sulistyaningrum N; Arlinda D; Hutagalung J; Sunarno S; Oktoberia IS; Handayani S; Ekowatiningsih R; Yusnita EA; Prasetyorini B; Rizki A; Tjitra E; Na-Bangchang K; Chaijaroenkul W
    Am J Trop Med Hyg; 2020 Aug; 103(2):760-766. PubMed ID: 32602432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primaquine ineligibility in anti-relapse therapy of Plasmodium vivax malaria: the problem of G6PD deficiency and cytochrome P-450 2D6 polymorphisms.
    Baird JK; Battle KE; Howes RE
    Malar J; 2018 Jan; 17(1):42. PubMed ID: 29357870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Origins and implications of neglect of G6PD deficiency and primaquine toxicity in Plasmodium vivax malaria.
    Baird K
    Pathog Glob Health; 2015 May; 109(3):93-106. PubMed ID: 25943156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting Plasmodium falciparum transmission with primaquine: same efficacy, improved safety with a lower dose?
    Chen IT; Gosling RD
    Expert Rev Clin Pharmacol; 2014 Nov; 7(6):681-6. PubMed ID: 25118908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modelling primaquine-induced haemolysis in G6PD deficiency.
    Watson J; Taylor WR; Menard D; Kheng S; White NJ
    Elife; 2017 Feb; 6():. PubMed ID: 28155819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Using G6PD tests to enable the safe treatment of Plasmodium vivax infections with primaquine on the Thailand-Myanmar border: A cost-effectiveness analysis.
    Devine A; Parmiter M; Chu CS; Bancone G; Nosten F; Price RN; Lubell Y; Yeung S
    PLoS Negl Trop Dis; 2017 May; 11(5):e0005602. PubMed ID: 28542194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improving the radical cure of vivax malaria (IMPROV): a study protocol for a multicentre randomised, placebo-controlled comparison of short and long course primaquine regimens.
    IMPROV Study Group
    BMC Infect Dis; 2015 Dec; 15():558. PubMed ID: 26643116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Real-life implementation of a G6PD deficiency screening qualitative test into routine vivax malaria diagnostic units in the Brazilian Amazon (SAFEPRIM study).
    Brito-Sousa JD; Murta F; Vitor-Silva S; Sampaio VS; Mendes MO; Brito MAM; Batista TSB; Santos APC; Marques LLG; Barbosa LRA; Melo MM; Baia-da-Silva DC; Silva-Neto AV; Santos TC; Souza BKA; Figueiredo EFG; Silva EL; Rodovalho S; Nakagawa TH; Arcanjo AR; Siqueira AM; Melo GC; Recht J; Domingo GJ; Bassat Q; Bancone G; Monteiro WM; Lacerda MVG
    PLoS Negl Trop Dis; 2021 May; 15(5):e0009415. PubMed ID: 34003840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tolerability and safety of primaquine in Papua New Guinean children 1 to 10 years of age.
    Betuela I; Bassat Q; Kiniboro B; Robinson LJ; Rosanas-Urgell A; Stanisic D; Siba PM; Alonso PL; Mueller I
    Antimicrob Agents Chemother; 2012 Apr; 56(4):2146-9. PubMed ID: 22252800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and distribution of G6PD deficiency: implication for the use of primaquine in malaria treatment in Ethiopia.
    Lo E; Zhong D; Raya B; Pestana K; Koepfli C; Lee MC; Yewhalaw D; Yan G
    Malar J; 2019 Oct; 18(1):340. PubMed ID: 31590661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The reality of using primaquine.
    Burgoine KL; Bancone G; Nosten F
    Malar J; 2010 Dec; 9():376. PubMed ID: 21184691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Association of methemoglobinemia and glucose-6-phosphate dehydrogenase deficiency in malaria patients treated with primaquine].
    Santana MS; da Rocha MA; Arcanjo AR; Sardinha JF; Alecrim WD; Alecrim Md
    Rev Soc Bras Med Trop; 2007; 40(5):533-6. PubMed ID: 17992408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and Efficacy of Adding a Single Low Dose of Primaquine to the Treatment of Adult Patients With Plasmodium falciparum Malaria in Senegal, to Reduce Gametocyte Carriage: A Randomized Controlled Trial.
    Tine RC; Sylla K; Faye BT; Poirot E; Fall FB; Sow D; Wang D; Ndiaye M; Ndiaye JL; Faye B; Greenwood B; Gaye O; Milligan P
    Clin Infect Dis; 2017 Aug; 65(4):535-543. PubMed ID: 28605472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An optimised age-based dosing regimen for single low-dose primaquine for blocking malaria transmission in Cambodia.
    Leang R; Khu NH; Mukaka M; Debackere M; Tripura R; Kheang ST; Chy S; Kak N; Buchy P; Tarantola A; Menard D; Roca-Felterer A; Fairhurst RM; Kheng S; Muth S; Ngak S; Dondorp AM; White NJ; Taylor WR
    BMC Med; 2016 Oct; 14(1):171. PubMed ID: 27784313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Haemolysis in G6PD Heterozygous Females Treated with Primaquine for Plasmodium vivax Malaria: A Nested Cohort in a Trial of Radical Curative Regimens.
    Chu CS; Bancone G; Moore KA; Win HH; Thitipanawan N; Po C; Chowwiwat N; Raksapraidee R; Wilairisak P; Phyo AP; Keereecharoen L; Proux S; Charunwatthana P; Nosten F; White NJ
    PLoS Med; 2017 Feb; 14(2):e1002224. PubMed ID: 28170391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map.
    Howes RE; Piel FB; Patil AP; Nyangiri OA; Gething PW; Dewi M; Hogg MM; Battle KE; Padilla CD; Baird JK; Hay SI
    PLoS Med; 2012; 9(11):e1001339. PubMed ID: 23152723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.